Dr. Daniel Labow: “Study Probes Use of MRI to Spot Pancreatic Cancer in High-Risk Patients”
Pancreatic cancer remains a "silent killer" because it is typically discovered too late for treatment to be very effective.
Pancreatic cancer remains a "silent killer" because it is typically discovered too late for treatment to be very effective. Now, a small new study hints -- but cannot prove -- that using MRIs to screen people at high genetic risk for the disease might help spot tumors early. The findings were published online April 8 in JAMA Surgery. Experts in the United States urged caution in interpreting the results of such a short, small trial, saying much more study is needed. One expert applauded the effort, at least. "Reducing the incidence of this disease, even for a few, is advantageous and further research into battling this deadly malignancy is needed," said Daniel Labow, MD, associate professor of surgery and surgical oncology at the Icahn School of Medicine at Mount Sinai, New York City. Learn more
-Dr. Daniel Labow, Associate Professor, Surgery, Surgical Oncology, Icahn School of Medicine at Mount Sinai
Mount Sinai Surgeons Remove Thyroid Gland Through Hidden Incision Underneath the Lip
Nov 30, 2016 View All Press Releases